InnaMed on Republic

Using smart, at-home blood testing technology to enable personalized medicine.

Raise to date: $1,070,000

Reporting Date: 07/31/2019

Key Stats

Minimum Raise

$50,000

Maximum Raise

$1,070,000

Likelihood of Max Unlikely
Start Date

04/30/2019

Stop Date

07/31/2019

Days Remaining

19999904

Security Type

SAFE

Investment Minimum

$60

Deal Type

Top Deal


Investment Summary

Status

Confirmed Closed

# of Investors

2

% of Minimum Raised

2,140%

% of Maximum Raised

100%

Dollars Per Day to Reach Max

N/A

DPD* Committed

$11,630

DPD* Category

$1,872

DPD* All Companies

$786

Kingscrowd Momentum

$1,070,000

Total Dollars Raised

Commitments

Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

InnaMed, with a valuation cap of $12 million, is raising crowdfunding on Republic. The company is developing an at-home testing device called TeleLab. The device can be filled with several disease-specific test cartridges and helps to monitor the patients remotely. InnaMed is using modern blood collection techniques, cloud computing, and its patented electrochemical blood analysis technology to provide lab-level testing at home. The company was founded by Eshwar Inapuri, Alan Jernigan, and Anup Singh in May 2016, and has already developed two prototypes. The proceeds of the crowdfunding round, with a minimum target of $50,000 and a maximum target of $1,070,000, will be used for clinical validation and beta testing of the device. InnaMed already has $400,000 in contracts with U.S. government agencies and a top global pharma company.

INVEST NOW